In Brief This Week: Cancer Genetics, Babraham Institute; UK Biobank; AB Sciex; Thermo Fisher Scientific; Agilent; More | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics this week launched its joint venture with the Mayo Clinic. Called OncoSpire Genomics, the new company will develop and commercialize diagnostic tests that leverage next-generation sequencing. OncoSpire is 50-50 owned by Cancer Genetics, which went public in April, and Mayo.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.